In Brief: Sanofi Commits $20bn To US R&D And Manufacturing By 2030

US Almost Half Of Firm’s Q1 Revenue

 
• By Sushmita Panda
  
Sanofi
Sanofi plans major new investments in US manufacturing and R&D • Source: Getty
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Scrip